Bioelectrical impedance phase angle as indicator and predictor of cachexia in head and neck cancer patients treated with (chemo)radiotherapy

European Journal of Clinical Nutrition

Volumn 70, Issue 5, 2016, Pages 602-606

  Stegel, P ^a   Kozjek, N R ^a   Brumen, B A ^a   Strojan, P ^a,b  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; CISPLATIN; HEMOGLOBIN;

ADULT; ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; BIOIMPEDANCE ANALYSIS; BODY MASS; CACHEXIA; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONSENSUS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GRIP STRENGTH; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MONOTHERAPY; MUSCLE STRENGTH; NUTRITIONAL ASSESSMENT; NUTRITIONAL RISK SCREENING 2002; NUTRITIONAL STATUS; PHASE ANGLE; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION; WEIGHT REDUCTION; AGED; CHEMORADIOTHERAPY; COMPLICATION; EVALUATION STUDY; HEAD AND NECK TUMOR; IMPEDANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

AGED; CACHEXIA; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; ELECTRIC IMPEDANCE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 84959123126     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2016.13     Document Type: Article

References (31)

1. Gorenc M, Kozjek NR, Strojan P. Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy. Rep Pract Oncol Radiother 2015; 20: 249-258.
2. Jager-Wittenaar H, Dijkstra PU, Vissink A, van der Laan BF, van Oort RP, Roo-denburg JL. Malnutrition and quality of life in patients treated for oral or oropharyngeal cancer. Head Neck 2011; 33: 490-496.
3. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Ad hoc ESPEN Working Group Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003; 22: 321-336.
4. Bozzetti F, Mariani L, Lo Vullo S. SCRINIO Working Group The nutritional risk in oncology: a study of 1, 453 cancer outpatients. Support Care Cancer 2012; 20: 1919-1928.
5. Blum D, Strasser F. Cachexia assessment tools. Curr Opin Support Palliat Care 2011; 5: 350-355.
6. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D et al. Cachexia: a new definition. Clin Nutr 2008; 27: 793-799.
7. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489-495.
8. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gómez J et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004; 23: 1430-1453.
9. Grundmann O, Yoon SL, Williams JJ. The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients-a comprehensive review. Eur J Clin Nutr 2015; 69: 1290-1297.
10. Visser M, van Venrooij LM, Wanders DC, de Vos R, Wisselink W, van Leeuwen PA et al. The bioelectrical impedance phase angle as an indicator of undernutrition and adverse clinical outcome in cardiac surgical patients. Clin Nutr 2012; 31: 981-986.
11. Małecka-Massalska T, Mlak R, Smolen A, Morshed K. Bioelectrical impedance phase angle and subjective global assessment in detecting malnutrition among newly diagnosed head and neck cancer patients. Eur Arch Otorhinolaryngol e-pub ahead of print 25 April 2015.
12. Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer 2009; 9: 37.
13. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. Educational and Clinical Practice Committee European Society of Parenteral and Enteral Nutrition (ESPEN). ESPEN guidelines for nutritional screening 2002. Clin Nutr 2003; 22: 415-421.
14. Peters MJ, van Nes SI, Vanhoutte EK, Bakkers M, van Doorn PA, Merkies IS et al. PeriNomS Study group Revised normative values for grip strength with the Jamar dynamometer. J Peripher Nerv Syst 2011; 16: 47-50.
15. Shechtman O, Gestewitz L, Kimble C. Reliability and validity of the DynEx dynamometer. J Hand Ther 2005; 18: 339-347.
16. Barbosa-Silva MC, Barros AJ. Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care 2005; 8: 311-317.
17. Bahadori B, Uitz E, Tonninger-Bahadori Y, Pestemer-Lach I, Trummer M, Thonhofer R et al. Body composition: the fat-free mass index (FFMI) and the body fat mass index (BF 374 MI) distribution among the adult Austrian population-results of a cross-sectional pilot study. Int J Body Comp Res 2006; 4: 123-128.
18. Bioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference Statement. Am J Clin Nutr 1996; 64(3 Suppl): 524S-532S.
19. De Luis DA, Aller R, Izaola O, Terroba MC, Cabezas G, Cuellar L. Tissue electric properties in head and neck cancer patients. Ann Nutr Metab 2006; 50: 7-10.
20. von Haehling S, Anker SD. Treatment of cachexia: an overview of recent developments. J Am Med Dir Assoc 2014; 15: 866-872.
21. Richey LM, George JR, Couch ME, Kanapkey BK, Yin X, Cannon T et al. Defining cancer cachexia in head and neck squamous cell carcinoma. Clin Cancer Res 2007; 13: 6561-6567.
22. Couch ME, Dittus K, Toth MJ, Willis MS, Guttridge DC, George JR et al. Cancer cachexia update in head and neck cancer: definitions and diagnostic features. Head Neck 2015; 37: 594-604.
23. Muscaritoli M, Bossola M, Bellantone R, Rossi Fanelli F. Therapy of muscle wasting in cancer: what is the future? Curr Opin Clin Nutr Metab Care 2004; 7: 459-466.
24. Yao JH, Zhang MF, Zhang HF, Ma BL, Yin QM, Tang W. Nutritional risk screening and enteral nutrition in patients with oral and maxillofacial cancers. Shanghai Kou Qiang Yi Xue 2011; 20: 101-105. [Article in Chinese].
25. Planas M, Álvarez-Hernández J, León-Sanz M, Celaya-Pérez S, Araujo K, García de Lorenzo A. PREDyCES® researchers Prevalence of hospital malnutrition in cancer patients: a sub-analysis of the PREDyCES® study. Support Care Cancer 2015; 24: 429-435.
26. Kyle UG, Genton L, Pichard C. Low phase angle determined by bioelectrical impedance analysis is associated with malnutition and nutritional risk at hospital admission. Clin Nutr 2013; 32: 294-299.
27. Norman K, Stobäus N, Zocher D, Bosy-Westphal A, Szramek A, Scheufele R et al. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr 2010; 92: 612-619.
28. Maggiore Q, Nigrelli S, Ciccarelli C, Grimaldi C, Rossi GA, Michelassi C. Nutritional and prognostic correlates of bioimpedance indexes in hemodialysis patients. Kidney Int 1996; 50: 2103-2108.
29. Barbosa-Silva MC, Barros AJ, Wang J, Heymsfield SB, Pierson RN Jr. Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr 2005; 82: 49-52.
30. Jager-Wittenaar H, Dijkstra PU, Vissink A, van Oort RP, van der Laan BFAM, Roo-denburg JL. Malnutrition in patients treated for oral or oropharyngeal cancer-prevalence and relationship with oral symptoms: an explorative study. Support Care Cancer 2011; 19: 1675-1683.
31. Strojan P, Stegel P, Rotovnik-Kozjek N. Assessment of nutritional status of head and neck carcinoma patients treated with radiochemotherapy. Zdrav Vestn 2005; 74: 233-238.